Medtronic, Inc. (NYSE: MDT) today announced a new United States investigational device exemption study to evaluate the accuracy of six-day use in adults with diabetes of its Enlite™ Sensor, the ...
Medtronic received FDA approval for its Enlite sensor for use with the firm’s iPro2 professional continuous glucose monitoring system. Previously available with the MiniMed 530G insulin pump, the ...
MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) announces the launch of Enlite™ Sensor, the newest and most advanced glucose sensor for continuous glucose monitoring (CGM), in more than 35 ...
Medtronic plcMDT recently announced the receipt of the U.S. FDA approval for its Enlite sensor, which is to be used with the iPro2 Professional Continuous Glucose Monitoring (CGM) system. This is ...
Medtronic plc MDT disclosed that the FDA has given its approval of the Enlite sensor for use with iPro2 Professional Continuous Glucose Monitoring (CGM) system. This is a market-leading CGM system, ...
MiniMed® 530G with Enlite Automatically Stops Insulin Delivery If Sensor Glucose Levels Fall Below a Predetermined Threshold MINNEAPOLIS - September 27, 2013 -Medtronic, Inc. (NYSE:MDT) today ...
With a great deal of hype, and a few delays from the US Food and Drug Administration (FDA), Medtronic in September 2013 released its newest combined pump and continuous glucose monitor (CGM), the ...
The FDA has approved the Enlite sensor for use with Medtronic’s iPro2 Professional Continuous Glucose Monitoring system, a disposable glucose sensor that can be worn for up to 6 days. The Enlite ...
When Medtronic won approval for the MiniMed 670G from the FDA in 2016, it was a big deal. Advertised as “The World’s First Hybrid Closed Loop System,” it is the first commercial product of its kind – ...
Medical device major Medtronic, Inc. ( MDT) has initiated the global launch of its latest blood glucose sensor - the MiniMed 640G System. Apart from monitoring a patient's blood glucose level, the ...
I recently had the chance to try out the latest in diabetes tech from Medtronic, conducting a 14-day test drive of the new Minimed Connect data display platform. This new system shows both insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results